Skip to content
Medical Health Aged Care

Australian women win: Vast majority of women’s health clinics in Australia’s first national network move to bulk billing

Evoca Women's Health 4 mins read

Sydney, 30 October 2025: Evoca Women’s Health (Evoca) – Australia’s first national network of GP-led women’s health clinics – is pleased to announce it will increase bulk billing across majority of its clinics, following recent Federal Government funding reforms delivered through the Strengthening Medicare Bulk Billing Incentive and Women’s Health Package.

Evoca operates 43 women’s health clinics across Australia, offering affordable care to thousands of women each year. From 1 November, 28 Evoca clinics (65%) will fully bulk bill eligible GP consults, with over 75% of the clinics expected to fully convert to bulk billing in the next 12 months. Access and affordability are priorities across all Evoca clinics with bulk billing available wherever possible and transparent, affordable fees in place where it is not.

This means thousands more women will be able to access key women’s health services for no cost at Evoca clinics nationwide. This includes menopause and fertility assessments, pelvic pain care, heavy bleeding and hormonal treatments.

In addition, the Government’s investment in Long-Acting Reversible Contraceptives (LARCs) will provide an increase in the rebates to patients for LARC procedures.

LARCs, which include intrauterine device (IUD) and implant insertion and removal, are contraceptive tools as well as treatments for endometriosis, heavy menstrual bleeding and menopause.[1] Average out-of-pocket costs range from $50 to more than $300 outside of Evoca clinics. This rebate makes LARC procedures more accessible to more women across more locations in Australia.

According to the National Clinical Director of Evoca, Dr Sneha Wadhwani, the rebate represents a major stride forward for women wanting to access high quality clinical services that are affordable and convenient.

"Evoca was established to meet the needs of women at various ages and stages of life, especially in demographics where access to care was limited and also unaffordable. We are thrilled that our passionate and skilled GPs will now be able to provide those services even more cost effectively, as two in every three of our clinics will be bulk billing," said Dr Wadhwani.

For many women, this shift could mean the difference between delaying care and getting timely help. By embracing the new changes, Evoca is helping to close a critical access gap, and delivering tangible health benefits across communities.

“This is about removing barriers to care that too many women still face,” said Dr Wadhwani. “When the cost of a consultation or a simple contraceptive procedure becomes a deciding factor, women’s health suffers and so does community health overall. By leading this change, Evoca is ensuring that holistic, women-centred care is no longer a privilege, but a reality.”

Evoca is pleased to announce that the LARC investments will enable the majority of trained Evoca GPs to offer bulk billed IUD and contraceptive implant services, with no cost to Medicare-eligible patients.

Over the last year, Evoca GPs have delivered over 2,500 LARC procedures, thanks to Evoca’s free, in-house clinical training program. Access for patients will continue to improve as additional GPs are trained through Evoca’s comprehensive education and clinical support package. This includes Evoca’s annual conference, monthly webinars and peer-to-peer support programs, which are designed to enable clinicians in the Evoca network to provide high standards of holistic women’s health care.

Cost has long been a barrier to accessing care, with one in ten Australians delaying or foregoing GP care.[2] Women are often disproportionately affected due to ongoing reproductive and hormonal healthcare requirements throughout their lives, which can lead to significant out-of-pocket fees for specialist or procedural care not fully covered by Medicare.[3]

Women’s health conditions such as endometriosis, heavy menstrual bleeding, menopause and pelvic pain contribute to thousands of lost workdays and substantial productivity costs each year.[4] By improving affordable access to GP-led women’s healthcare nationwide, Evoca and its GPs are contributing to reduced hospital admissions, specialist waitlists and long-term economic burden.

ENDS

This media release was distributed on behalf of Evoca Women’s Health.

For all media enquiries, please contact Palin Communications: 

Tina Kandelaki

Palin Communications

+61 410 162 251

[email protected]  

Anastasiia Nazarenko

Palin Communications

+61 435 977 559

[email protected]  

About Evoca Women’s Health 

Evoca Women’s Health (Evoca) is part of the ForHealth Group, the largest Bulk Billing General Practice provider in Australia, with a mission of accessible, holistic healthcare for women. Evoca clinics offer convenient and modern facilities with GPs, physios, dietetics, other allied health specialists, Women’s Health Specialists, imaging, pathology, and pharmacy often all at one site. For more information, visit: https://evocawomenshealth.com.au/

Evoca is Australia’s first and largest national network of General Practitioners specialising in women’s health services. It comprises over 40 clinics in outer metro and regional areas, with over 115 women’s healthcare professionals handpicked for their skills in offering individualised and evidence-based care in all areas of women’s health from contraception, endometriosis fertility and pregnancy to menopause and everything in between.

Evoca is passionate about developing a community of likeminded women’s health professionals and as such offers monthly webinars, an annual conference with expert speakers, IUD and contraceptive implants training and supervision, peer-to-peer support and much more. Evoca is also proud to run two of the Federally funded Endometriosis and Pelvic Pain clinics.

References


[1] Magraith K, et al. Long-acting reversible contraception. Australian Prescriber. 2023;46(3):48–53. Available at: https://australianprescriber.tg.org.au/assets/AP/pdf/Vol_46_Issue_3/p48-Magraith-et-al.pdf

[2] AIHW Medicare Bulk billing and out-of-pocket costs for GP attendances over time. December 2024. Available at: https://www.aihw.gov.au/reports/medicare/medicare-bulk-billing-of-gp-attendances-over-time/contents/introduction?utm

[3] Australian Government Department of Health. National Women’s Health Strategy 2020–2030. Canberra. 2020. Available at: https://www.health.gov.au/sites/default/files/documents/2021/05/national-women-s-health-strategy-2020-2030_0.pdf

[4] Bankwest Curtin Economics Centre. The Costs And Benefits Of Implementing A Universal Reproductive Health Leave Entitlement In Australia 2025. Available at: https://bcec.edu.au/assets/2025/04/BCEC-Paid-Reproductive-Health-Leave-Report-20250408.pdf

More from this category

  • Medical Health Aged Care, Women
  • 08/03/2026
  • 07:00
Monash University

What women really want re their health – and why they can’t always get it

What women really want re their health – and why they can’t always get it The most comprehensive study of the health conditions and social issues affecting women and girls in Australia has just been published by Monash University researchers and The Sisterhood Foundation. It reveals that women’s and girls’ health is often overlooked, underfunded, and misunderstood. The study found that the health system, researchers and the media mostly think about women’s health in terms of their reproductive health. However, there is a need to go ‘beyond the bikini line’ and focus on all aspects of women’s and girls’ health…

  • Medical Health Aged Care
  • 06/03/2026
  • 19:10
Claritas HealthTech Ltd

Claritas iPET(TM) Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPET™ for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPET™, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital…

  • Medical Health Aged Care
  • 06/03/2026
  • 15:57
Dementia Australia

Cronulla comes together for people impacted by dementia

Friday 6 March 2026 Cronulla comes together for people impacted by dementia Cronulla community members tied up their laces and showed up in force last weekend for the 2026 Cronulla Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 760 people walked, ran and jogged to the finish line to raise an impressive total of $103,430. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Cronulla community…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.